HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ARTemis Investigators Selected Research

Docetaxel (Taxotere)

6/2015Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


ARTemis Investigators Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
06/2015

Drug/Important Bio-Agent (IBA)

1Bevacizumab (Avastin)FDA Link
06/2015
1Docetaxel (Taxotere)FDA Link
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015
1Fluorouracil (Carac)FDA LinkGeneric
06/2015
1Epirubicin (Ellence)FDA LinkGeneric
06/2015

Therapy/Procedure

1Neoadjuvant Therapy
06/2015